Incisional Hernia Rate After Single-incision Laparoscopic Cholecystectomy

Status Completed

Clinical Trial Summary

Single-incision laparoscopic cholecystectomy (SILC) requires a larger incision than standard laparoscopy, which may increase the incidence of incisional hernias.

This study evaluated SILC and standard multiport cholecystectomy with respect to perioperative outcomes, hospital stay, cosmetic results, and postoperative complications, including the 5-years incisional hernia rate.

Clinical Trial Description

A cohort study was performed for patients who underwent a laparoscopic cholecystectomy under an institutional review approved protocol. Between 2009 and 2011, 45 unselected patients underwent SILC performed by the same two surgeons.

The study inclusion criteria were the following: patients over 18 years with cholelithiasis, and candidates for elective surgery with no significant cardiopulmonary, hepatic or renal impairment (ASA score less than 4).

The exclusion criteria included the following: acute cholecystitis, associated CBD stones or pancreatitis, an emergency operation for complicated disease, mental illness, or patient refusal and/or absence of informed consent. All included patients signed a standard consent form after being informed about the characteristics of the SILC procedure.

The outcomes of these patients were compared with those of a control cohort series of 140 patients who underwent standard LC (with the same inclusion and exclusion criteria) during the same period.

The primary endpoint of the study was to determine the incisional hernia rate at the umbilical wound after 5 years of follow-up. Hernias were defined as evidence of a hernia at the clinical examination or those confirmed by ultrasound examination in case of clinical doubt.

The study secondary endpoints included the following: duration of surgery (from the start of the incision to skin closure), intraoperative and postoperative complications (30 days), hospital stay, and cosmetic satisfaction results (measured using a visual analogue scale score ranging from 0 to 10).

The following variables were also collected: age, gender, body mass index (BMI) and comorbidities. The anesthetic risk was measured according to the ASA classification system. Prolonged hospital stay (more than 24 h) and readmission (patients who returned for medical consultation before scheduled follow-up) were also recorded. All data were collected prospectively. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03768661
Study type	Observational
Source	Hospital Plató
Contact
Status	Completed
Phase
Start date	July 1, 2009
Completion date	November 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00616616` - Single Incision Laparoscopy	N/A
Completed	`NCT00530998` - Minimally Invasive Surgery: Using Natural Orfices
Recruiting	`NCT00416234` - Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis	N/A
Recruiting	`NCT05975385` - Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT06038201` - Cholecystectomy vs EUS-guided GBD With Stone Removal	N/A
Not yet recruiting	`NCT03981315` - Bile Composition in Healthy and Gallstones Patients
Completed	`NCT01824186` - Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy	N/A
Completed	`NCT00606762` - Comparison Between Low Pressure Versus High Pressure Laparoscopic Cholecystectomy	N/A
Completed	`NCT00971750` - Laparoscopic Versus Transabdominal Ultrasound in Morbidly Obese Patients	N/A
Active, not recruiting	`NCT04279223` - Does Using a 5 mm Telescope in Laparoscopic Cholecystectomy Reduce the Incidence of Trocar Site Hernia?	N/A
Terminated	`NCT01708109` - Optimal Handling of Common Bile Duct Calculus, a Prospective Study	N/A
Completed	`NCT01881399` - Fluorescence Versus Intraoperative Cholangiography in the Visualization of Biliary Tree Anatomy	N/A
Withdrawn	`NCT01146184` - Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)	N/A
Terminated	`NCT00910325` - Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy	Phase 1/Phase 2
Completed	`NCT04672902` - Treatment of Mirizzi Syndrome
Completed	`NCT03180229` - Granisetron Effect on Hemodynamic Changes in Laparoscopic Cholecystectomy	Phase 4
Completed	`NCT02375529` - A Trial of Single Incision Versus Four Ports Laparoscopic Cholecystectomy	N/A
Not yet recruiting	`NCT01339325` - Laparo-endoscopic Single Site (LESS) Cholecystectomy Versus Standard LAP-CHOLE	Phase 4
Terminated	`NCT00486655` - NOTES-Assisted Laparoscopic Cholecystectomy Surgery	N/A
Completed	`NCT00131131` - Epidemiology of Gallbladder Sludge and Stones in Pregnancy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.